| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26402-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | MAB33541-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22614-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82112-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21788-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21506-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21552-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-81931-0.025ml | |||
![Immunohistochemistry: Nrf2 [p Ser40] Antibody (2E6) [NBP3-26402] - Image of Nrf2 [p Ser40] Antibody diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26402_rabbit-nrf2-p-ser-40-mab-2e6-2722024850464.jpg "Immunohistochemistry: Nrf2 [p Ser40] Antibody (2E6) [NBP3-26402] - Image of Nrf2 [p Ser40] Antibody diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.")
![Western Blot: Nrf2 [p Ser40] Antibody (2E6) [NBP3-26402] - Positive Western Blot detected in HepG2 whole cell lysate, 293 whole cell lysate (treated with Calyculin A or EGF). All lanes: Nrf2 [p Ser40] Antibody at 0.8ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 90 KDa Observed band size: 90 KDa](http://images.novusbio.com/fullsize/nbp3-26402_rabbit-nrf2-p-ser-40-mab-2e6-282202411351612.jpg)
![Immunocytochemistry/Immunofluorescence: Nrf2 [p Ser40] Antibody (2E6) [NBP3-26402] - Staining of Hela cells with Nrf2 [p Ser40] Antibody (2E6) at 1:100, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26402_rabbit-nrf2-p-ser-40-mab-2e6-282202412475116.jpg)
![Immunohistochemistry: XRCC1 [p Ser461] Antibody [NB100-533] - Samples: FFPE serial sections of human larynx squamous cell carcinoma. Mock phosphatase treated section (left) and calf intestinal phosphatase-treated section (right). Antibody: Affinity purified rabbit anti-Phospho XRCC1 (S461). used at a dilution of 1:1](http://images.novusbio.com/fullsize/XRCC1-[p-Ser461]-Antibody-Immunohistochemistry-NB100-533-img0006.jpg "Immunohistochemistry: XRCC1 [p Ser461] Antibody [NB100-533] - Samples: FFPE serial sections of human larynx squamous cell carcinoma. Mock phosphatase treated section (left) and calf intestinal phosphatase-treated section (right). Antibody: Affinity purified rabbit anti-Phospho XRCC1 (S461). used at a dilution of 1:1")
![Immunohistochemistry-Paraffin: XRCC1 [p Ser461] Antibody [NB100-533] - FFPE serial sections of human breast adenocarcinoma. Mock phosphatase treated section (left) or calf intestinal phosphatase-treated section (right) immunostained for Phospho XRCC1 (S461). Antibody: Affinity purified rabbit anti-Phospho XRCC1 (S461). used at a dilution of 1:250. Detection: DAB staining using Immunohistochemistry Accessory Ki](http://images.novusbio.com/fullsize/XRCC1-[p-Ser461]-Antibody-Immunohistochemistry-Paraffin-NB100-533-img0003.jpg)
![Immunohistochemistry-Paraffin: XRCC1 [p Ser461] Antibody [NB100-533] - Mouse Phospho XRCC1 (S461). Sample: FFPE section of mouse squamous cell carcinoma. Antibody: Affinity purified rabbit anti-Phospho XRCC1 (S461) dilution-1:250.](http://images.novusbio.com/fullsize/XRCC1-[p-Ser461]-Antibody-Immunohistochemistry-Paraffin-NB100-533-img0002.jpg)
![Immunohistochemistry: MLF1 Interacting Protein Antibody - BSA Free [NBP3-45908] - Immunohistochemistry of paraffin-embedded human testis tissue slide using (MLF1 Interacting Protein Antibody) at dilution of 1:50](http://images.novusbio.com/fullsize/nbp3-45908_rabbit-mlf1-interacting-protein-pab-bsa-free-284202511483442.jpg "Immunohistochemistry: MLF1 Interacting Protein Antibody - BSA Free [NBP3-45908] - Immunohistochemistry of paraffin-embedded human testis tissue slide using (MLF1 Interacting Protein Antibody) at dilution of 1:50")
![Western Blot: MLF1 Interacting Protein Antibody - BSA Free [NBP3-45908] - HepG2 cells were subjected to SDS PAGE followed by western blot with (MLF1 Interacting Protein antibody) at dilution of 1:500](http://images.novusbio.com/fullsize/nbp3-45908_rabbit-mlf1-interacting-protein-pab-bsa-free-284202511513460.jpg)
![Immunoprecipitation: MAP4 Antibody - BSA Free [NBP3-45960] - IP Result of anti-MAP4 (IP: , 4ug; Detection: 1:1000) with HEK-293 cells lysate 1200ug.](http://images.novusbio.com/fullsize/nbp3-45960_rabbit-map4-pab-bsa-free-284202511524796.jpg "Immunoprecipitation: MAP4 Antibody - BSA Free [NBP3-45960] - IP Result of anti-MAP4 (IP: , 4ug; Detection: 1:1000) with HEK-293 cells lysate 1200ug.")
![Immunohistochemistry: MAP4 Antibody - BSA Free [NBP3-45960] - Immunohistochemistry of paraffin-embedded human oesophagus cancer tissue slide using (MAP4 Antibody) at dilution of 1:200 heat mediated antigen retrieved with Tris-EDTA buffer(MAP4](http://images.novusbio.com/fullsize/nbp3-45960_rabbit-map4-pab-bsa-free-284202511543925.jpg)
![Western Blot: MAP4 Antibody - BSA Free [NBP3-45960] - HEK-293 cells were subjected to SDS PAGE followed by western blot with (MAP4 Antibody) at dilution of 1:600](http://images.novusbio.com/fullsize/nbp3-45960_rabbit-map4-pab-bsa-free-284202511561888.jpg)
![Western Blot: MCM2 Antibody (S02-0D3) [NBP3-19887] - Western blot detection of MCM2 in Hela, A549, HL-60, U2OS cell lysates using NBP3-19887 (1:1000 diluted). Predicted band size: 102kDa. Observed band size: 125kDa.](http://images.novusbio.com/fullsize/MCM2-Antibody-S02-0D3-Western-Blot-NBP3-19887-img0003.jpg "Western Blot: MCM2 Antibody (S02-0D3) [NBP3-19887] - Western blot detection of MCM2 in Hela, A549, HL-60, U2OS cell lysates using NBP3-19887 (1:1000 diluted). Predicted band size: 102kDa. Observed band size: 125kDa.")
![Immunohistochemistry-Paraffin: MCM2 Antibody (S02-0D3) [NBP3-19887] - Immunohistochemistry of MCM2 in paraffin-embedded Human tonsil using NBP3-19887 at dilution 1/50](http://images.novusbio.com/fullsize/MCM2-Antibody-S02-0D3-Immunohistochemistry-Paraffin-NBP3-19887-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: MCM2 Antibody (S02-0D3) [NBP3-19887] - Immunocytochemistry of MCM2 (green) in hela using NBP3-19887 at dilution 1/5, and DAPI (blue)](http://images.novusbio.com/fullsize/nbp3-19887_rabbit-mcm2-mab-s02-0d3-113202515145446.jpg)
![Western Blot: AKT1/2/3 Antibody (SR2003) [NBP3-22614] - Western blot analysis using NBP3-22614 in (1) Hela cell lysate;(2) A549 cell lysate.](http://images.novusbio.com/fullsize/nbp3-22614_rabbit-akt1-2-3-mab-sr2003-57202317215156.jpg "Western Blot: AKT1/2/3 Antibody (SR2003) [NBP3-22614] - Western blot analysis using NBP3-22614 in (1) Hela cell lysate;(2) A549 cell lysate.")
![Western Blot: DOK1 [p Tyr362] Antibody [NB100-82112] - Analysis of extracts from Jurkat cells untreated or treated with insulin using NB100-82112](http://images.novusbio.com/fullsize/DOK1-[p-Tyr362]-Antibody-Western-Blot-NB100-82112-img0001.jpg "<b>Biological Strategies Validation. </b>Western Blot: DOK1 [p Tyr362] Antibody [NB100-82112] - Analysis of extracts from Jurkat cells untreated or treated with insulin using NB100-82112")
![<b>Biological Strategies Validation. </b>Western Blot: DOK1 [p Tyr362] Antibody [NB100-82112] - Western blot analysis of extracts from JK cells, treated with G-CSF or calf intestinal phosphatase (CIP)](http://images.novusbio.com/fullsize/DOK1-[p-Tyr362]-Antibody-Western-Blot-NB100-82112-img0004.jpg)
![Immunohistochemistry-Paraffin: DOK1 [p Tyr362] Antibody [NB100-82112] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue, using NB100-82112(left) or the same antibody preincubated with blocking peptide (right).](http://images.novusbio.com/fullsize/nb100-82112_rabbit-polyclonal-dok1-p-tyr362-antibody-103202523464515.jpg)
![Western Blot: CRMP2 Antibody (SR2080) [NBP3-21788] - Western blot analysis using NBP3-21788 in (1) U87-MG cell lysate; (2) NIH/3T3 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21788_rabbit-crmp2-mab-sr2080-57202315584822.jpg "Western Blot: CRMP2 Antibody (SR2080) [NBP3-21788] - Western blot analysis using NBP3-21788 in (1) U87-MG cell lysate; (2) NIH/3T3 cell lysate.")
![Immunohistochemistry: eIF2 alpha/EIF2S1 [p Ser 51] Antibody (SR1604) [NBP3-21506] - Immunohistochemical analysis of paraffin-embedded human colon cancer, using NBP3-21506.](http://images.novusbio.com/fullsize/nbp3-21506_rabbit-eif2-alpha-eif2s1-p-ser-51-mab-sr1604-5720231595524.jpg "Immunohistochemistry: eIF2 alpha/EIF2S1 [p Ser 51] Antibody (SR1604) [NBP3-21506] - Immunohistochemical analysis of paraffin-embedded human colon cancer, using NBP3-21506.")
![Western Blot: eIF2 alpha/EIF2S1 [p Ser 51] Antibody (SR1604) [NBP3-21506] - Western blot analysis using NBP3-21506 in (1)HeLa cell lysates treated with Calyculin A;(2) Untreated HeLa cell lysates.](http://images.novusbio.com/fullsize/nbp3-21506_rabbit-eif2-alpha-eif2s1-p-ser-51-mab-sr1604-6720231051267.jpg)
![Western Blot: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Western blot analysis using NBP3-21552 in (1) HeLa treated with AP; (2) HeLa cell lysate.](http://images.novusbio.com/fullsize/nbp3-21552_rabbit-cdk2-p-tyr-15-mab-sr1560-57202317215182.jpg "Western Blot: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Western blot analysis using NBP3-21552 in (1) HeLa treated with AP; (2) HeLa cell lysate.")
![Immunohistochemistry: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Immunohistochemical analysis of paraffin-embedded human bladder cancer, using NBP3-21552.](http://images.novusbio.com/fullsize/nbp3-21552_rabbit-cdk2-p-tyr-15-mab-sr1560-5720231564720.jpg)
![Western Blot: G3BP1 [p Ser232] Antibody [NB100-81931] - Analysis of extracta from 293 cells untreated or treated with starvation using G3B P-1 Antibody.](http://images.novusbio.com/fullsize/G3BP1-[p-Ser232]-Antibody-Western-Blot-NB100-81931-img0004.jpg "<b>Biological Strategies Validation. </b>Western Blot: G3BP1 [p Ser232] Antibody [NB100-81931] - Analysis of extracta from 293 cells untreated or treated with starvation using G3B P-1 Antibody.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/ Immunofluorescence: G3BP1 [p Ser232] Antibody - BSA Free [NB100-81931] - Immunofluorescence staining of methanol-fixed Hela cells using NB100-81931.](http://images.novusbio.com/fullsize/nb100-81931_rabbit-polyclonal-g3bp1-p-ser232-antibody-103202523464516.jpg)
![Immunohistochemistry-Paraffin: G3BP1 [p Ser232] Antibody [NB100-81931] - Analysis of Human Breast Carcinoma tissue using NB100-81931 (left) or the same antibody preincubated with blocking peptide (right)](http://images.novusbio.com/fullsize/nb100-81931_rabbit-polyclonal-g3bp1-p-ser232-antibody-10320252332103.jpg)